Enzyme treatments are being probed by conventional research scientists. They are proving us right. Scientists are bringing out an enzyme they call keratinase, but we call Karribatakoe.

Ingesting the GRAZOPH TEMUNA herbs with spirulina provides materials and instructions for the body to produce specific enzymes. Reports of two of these enzymes along with spirulina to treat Alzheimer's or related conditions are presented below.

Are doctors and pharmaceutical companies opposed to enzyme therapy because it clears up the problems, as opposed to promoting artificial drugs that treat symptoms but not the underlying cause?




Monday, 5-Jan-2004 4:50PM EST
Copyright 2004 by United Press International
Jan. 5 (UPI) -- North Carolina researchers have shown that an enzyme can fully degrade the prion -- or protein particle -- believed responsible for mad cow disease.

Research by North Carolina State University and scientists from the Netherlands and BioResource International, have shown that, under proper conditions, the enzyme can fully degrade the prion believed to be the cause of bovine spongiform encephalopathy, as well as the human and sheep versions, called Creutzfeldt-Jakob disease and scrapie.

The research, published in the Journal of Infectious Diseases, tested the effects of a bacterial enzyme keratinase on brain tissues from cows with BSE and sheep with scrapie. When the tissue was pretreated and in the presence of a detergent, the enzyme fully degraded the prion, rendering it undetectable.

"Our work has been done in vitro, or in test tubes, and we've reduced the prion to undetectable levels," said Dr. Jason Shih, professor of biotechnology and poultry science at North Carolina State. "Our work with mice will show whether these undetectable levels of prion are indeed non-infectious."

The researchers plan a two-year study, funded with $190,000 from the National Cattleman's Beef Association, to test the effectiveness of the enzyme on the treated BSE prions in mice.

Japanese team finds enzyme that stops Alzheimer's disease
The Japan Times May 25, 2001

Researchers at an affiliate of a Japanese government-backed research institute said they have discovered that an enzyme in the brain plays a key role in preventing or delaying the development of Alzheimer's disease, the U.S. magazine Science reported Friday. News of the discovery comes two days after the announcement that a team of researchers led by a Keio University professor has found a gene that prevents brain cells from deteriorating from Alzheimer's.

Alzheimer's, a neurodegenerative disease, kills neuronal cells and shrinks the brain, causing dementia. A research team led by Takaomi Saido of the Saitama Prefecture-based Riken Brain Science Institute, an affiliate of the Institute of Physical and Chemical Research, discovered through experiments on mice that the enzyme Neprilysin "cleans up" Beta-amyloid, a substance that destroys brain cells.

This mechanism is considered to be crucial in preventing Alzheimer's or delaying its symptoms, as Neprilysin is known to decompose accumulated Beta-amyloid.

The experiments involved the use of normal mice and those that had been genetically modified so that they were unable to produce Neprilysin. The team found that the decomposition capability of the normal mice was, at maximum, double that of those without Neprilysin. Mice that had inherited a genetic abnormality from only one parent also showed a lower decomposition capability than normal mice.

Most Alzheimer's patients have roughly the same amount of Beta-amyloid in the brain as healthy people, and it is thus not known how the disease starts to develop. The discovery suggests, however, that some people inherently carry less active Neprilysin and that these people develop the disease as they grow older, with their clean-up mechanism becoming inefficient, the team said. The team expects that genetic therapy will be able to be applied to patients whose Neprilysin has become less active, should studies on the enzyme at the genetic level proceed.

The Japan Times: May 25, 2001 (C) All rights reserved

Discovery of Spirulina Relative in Treating Alzheimer's

Can Pond Scum Compound Fight Alzheimer's?

MedicalNewsToday.com 29 Dec 2005:
A compound isolated from a cyanobacterium, a type of blue-green algae known as Nostoc, shows promise of becoming a natural drug candidate for fighting Alzheimer's and other neurodegenerative diseases, according to an in vitro study by researchers in Switzerland. It is believed to be the first time that a potent agent against Alzheimer's has been isolated from cyanobacteria, commonly known as 'pond scum.' The study was published in the Dec. 26 issue of the Journal of Natural Products, a monthly peer-reviewed joint publication of the American Chemical Society and the American Society of Pharmacognosy.

Full article is here.